- The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine. Avgeropoulou, C., Andreadou, I., Markantonis-Kyroudis, S., Demopoulou, M., Missovoulos, P., Androulakis, A., Kallikazaros, I. Eur. J. Heart Fail. (2005)